| __timestamp | BioCryst Pharmaceuticals, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 621276000 |
| Thursday, January 1, 2015 | 46361000 | 737887000 |
| Friday, January 1, 2016 | 23654000 | 907234000 |
| Sunday, January 1, 2017 | 23484000 | 1071860000 |
| Monday, January 1, 2018 | 20182000 | 1175948000 |
| Tuesday, January 1, 2019 | 44734000 | 1344582000 |
| Wednesday, January 1, 2020 | 16136000 | 1336183000 |
| Friday, January 1, 2021 | 149906000 | 1375760000 |
| Saturday, January 1, 2022 | 264233000 | 1612370000 |
| Sunday, January 1, 2023 | 326751000 | 1842161000 |
| Monday, January 1, 2024 | 2273680000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, financial performance is a key indicator of a company's success and potential. This analysis focuses on the gross profit trends of two prominent players: BioMarin Pharmaceutical Inc. and BioCryst Pharmaceuticals, Inc., from 2014 to 2023.
BioMarin has consistently outperformed BioCryst, with its gross profit growing by approximately 196% over the decade, peaking at $1.84 billion in 2023. In contrast, BioCryst's gross profit, while significantly lower, has shown remarkable growth, increasing by over 2300% to reach $326.75 million in the same year.
This stark contrast highlights BioMarin's established market presence and BioCryst's rapid growth trajectory. Investors and industry analysts should note these trends as they reflect the companies' strategic positioning and potential for future growth in the competitive biotech landscape.
Merck & Co., Inc. and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Analysis: Comparing Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Genmab A/S and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Incyte Corporation and BioMarin Pharmaceutical Inc. Trends
Who Generates Higher Gross Profit? Viatris Inc. or BioMarin Pharmaceutical Inc.
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Jazz Pharmaceuticals plc
Gross Profit Trends Compared: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.